Nia Health, a Berlin, Germany-based digital solutions company focused on providing treatment and support to people suffering from chronic skin conditions, raised €3.5M in Seed funding.
The round was led by High-Tech Gründerfonds. Other investors included adesso ventures, Ventura BioMed Investors, the fund of Dr. Kurt Schwarz.
The company intends to use the funds to expand the market share in German-speaking countries, launch in other EU countries in the next 24 months, prepare for the US market entry, and further develop the AI-based technology that integrates machine vision, natural language processing and teledermatology.
RELATED: Manus Neurodynamica secures £2.6m funding to advance NeuroMotor Pen
Co-founded by Oliver Welter & Tobias Seidl, Nia Health is a spin-off of the Charité Universitätsmedizin Berlin which develops a clinical diagnosis and therapy system for the continuous digital support of patients with chronic skin conditions. With its machine vision approach, Nia Health enables accurate documentation of disease and therapy progression and thus optimised treatment. The company works closely with German patient associations and leading clinicians and has already won reputable customers from the insurance and pharmaceutical industries. Amongst others, the Berlin-based company has developed the apps in the fields of atopic dermatitis (Nia) and psoriasis (Sorea), which were the first digital medical products of their kind to be approved worldwide. The digital medical solutions from Nia Health provide daily support for thousands of patients and their families.
